Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses an unprecedented public health crisis. Evidence suggests that SARS-CoV-2 infection causes dysregulation of the immune system. However, the unique signature of early immune responses remains elusive. We characterized the...

Full description

Saved in:
Bibliographic Details
Published inCell host & microbe Vol. 29; no. 2; pp. 222 - 235.e4
Main Authors Guo, Qirui, Zhao, Yingchi, Li, Junhong, Liu, Jiangning, Yang, Xiuhong, Guo, Xuefei, Kuang, Ming, Xia, Huawei, Zhang, Zeming, Cao, Lili, Luo, Yujie, Bao, Linlin, Wang, Xiao, Wei, Xuemei, Deng, Wei, Wang, Nan, Chen, Luoying, Chen, Jingxuan, Zhu, Hua, Gao, Ran, Qin, Chuan, Wang, Xiangxi, You, Fuping
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 10.02.2021
The Authors. Published by Elsevier Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses an unprecedented public health crisis. Evidence suggests that SARS-CoV-2 infection causes dysregulation of the immune system. However, the unique signature of early immune responses remains elusive. We characterized the transcriptome of rhesus macaques and mice infected with SARS-CoV-2. Alarmin S100A8 was robustly induced in SARS-CoV-2-infected animal models as well as in COVID-19 patients. Paquinimod, a specific inhibitor of S100A8/A9, could rescue the pneumonia with substantial reduction of viral loads in SARS-CoV-2-infected mice. Remarkably, Paquinimod treatment resulted in almost 100% survival in a lethal model of mouse coronavirus infection using the mouse hepatitis virus (MHV). A group of neutrophils that contributes to the uncontrolled pathological damage and onset of COVID-19 was dramatically induced by coronavirus infection. Paquinimod treatment could reduce these neutrophils and regain anti-viral responses, unveiling key roles of S100A8/A9 and aberrant neutrophils in the pathogenesis of COVID-19, highlighting new opportunities for therapeutic intervention. [Display omitted] •S100A8 is dramatically upregulated in SARS-CoV-2-infected animal models and patients•A group of aberrant immature neutrophils is induced during SARS-CoV-2 infection•Immune disorder is mediated by the S100A8/A9-TLR4 pathway•S100A8/A9 inhibitor, Paquinimod, could prevent COVID-19-associated immune disorder Guo et al. demonstrate that over-activation of S100A8/A9-TLR4 signaling results in immune imbalance and expansion of aberrant immature neutrophils during SARS-CoV-2 infection. Relevant therapeutic targets were validated in animal infection models.
AbstractList The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses an unprecedented public health crisis. Evidence suggests that SARS-CoV-2 infection causes dysregulation of the immune system. However, the unique signature of early immune responses remains elusive. We characterized the transcriptome of rhesus macaques and mice infected with SARS-CoV-2. Alarmin S100A8 was robustly induced in SARS-CoV-2-infected animal models as well as in COVID-19 patients. Paquinimod, a specific inhibitor of S100A8/A9, could rescue the pneumonia with substantial reduction of viral loads in SARS-CoV-2-infected mice. Remarkably, Paquinimod treatment resulted in almost 100% survival in a lethal model of mouse coronavirus infection using the mouse hepatitis virus (MHV). A group of neutrophils that contributes to the uncontrolled pathological damage and onset of COVID-19 was dramatically induced by coronavirus infection. Paquinimod treatment could reduce these neutrophils and regain anti-viral responses, unveiling key roles of S100A8/A9 and aberrant neutrophils in the pathogenesis of COVID-19, highlighting new opportunities for therapeutic intervention.The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses an unprecedented public health crisis. Evidence suggests that SARS-CoV-2 infection causes dysregulation of the immune system. However, the unique signature of early immune responses remains elusive. We characterized the transcriptome of rhesus macaques and mice infected with SARS-CoV-2. Alarmin S100A8 was robustly induced in SARS-CoV-2-infected animal models as well as in COVID-19 patients. Paquinimod, a specific inhibitor of S100A8/A9, could rescue the pneumonia with substantial reduction of viral loads in SARS-CoV-2-infected mice. Remarkably, Paquinimod treatment resulted in almost 100% survival in a lethal model of mouse coronavirus infection using the mouse hepatitis virus (MHV). A group of neutrophils that contributes to the uncontrolled pathological damage and onset of COVID-19 was dramatically induced by coronavirus infection. Paquinimod treatment could reduce these neutrophils and regain anti-viral responses, unveiling key roles of S100A8/A9 and aberrant neutrophils in the pathogenesis of COVID-19, highlighting new opportunities for therapeutic intervention.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses an unprecedented public health crisis. Evidence suggests that SARS-CoV-2 infection causes dysregulation of the immune system. However, the unique signature of early immune responses remains elusive. We characterized the transcriptome of rhesus macaques and mice infected with SARS-CoV-2. Alarmin S100A8 was robustly induced in SARS-CoV-2-infected animal models as well as in COVID-19 patients. Paquinimod, a specific inhibitor of S100A8/A9, could rescue the pneumonia with substantial reduction of viral loads in SARS-CoV-2-infected mice. Remarkably, Paquinimod treatment resulted in almost 100% survival in a lethal model of mouse coronavirus infection using the mouse hepatitis virus (MHV). A group of neutrophils that contributes to the uncontrolled pathological damage and onset of COVID-19 was dramatically induced by coronavirus infection. Paquinimod treatment could reduce these neutrophils and regain anti-viral responses, unveiling key roles of S100A8/A9 and aberrant neutrophils in the pathogenesis of COVID-19, highlighting new opportunities for therapeutic intervention. Guo et al. demonstrate that over-activation of S100A8/A9-TLR4 signaling results in immune imbalance and expansion of aberrant immature neutrophils during SARS-CoV-2 infection. Relevant therapeutic targets were validated in animal infection models.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses an unprecedented public health crisis. Evidence suggests that SARS-CoV-2 infection causes dysregulation of the immune system. However, the unique signature of early immune responses remains elusive. We characterized the transcriptome of rhesus macaques and mice infected with SARS-CoV-2. Alarmin S100A8 was robustly induced in SARS-CoV-2-infected animal models as well as in COVID-19 patients. Paquinimod, a specific inhibitor of S100A8/A9, could rescue the pneumonia with substantial reduction of viral loads in SARS-CoV-2-infected mice. Remarkably, Paquinimod treatment resulted in almost 100% survival in a lethal model of mouse coronavirus infection using the mouse hepatitis virus (MHV). A group of neutrophils that contributes to the uncontrolled pathological damage and onset of COVID-19 was dramatically induced by coronavirus infection. Paquinimod treatment could reduce these neutrophils and regain anti-viral responses, unveiling key roles of S100A8/A9 and aberrant neutrophils in the pathogenesis of COVID-19, highlighting new opportunities for therapeutic intervention.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses an unprecedented public health crisis. Evidence suggests that SARS-CoV-2 infection causes dysregulation of the immune system. However, the unique signature of early immune responses remains elusive. We characterized the transcriptome of rhesus macaques and mice infected with SARS-CoV-2. Alarmin S100A8 was robustly induced in SARS-CoV-2-infected animal models as well as in COVID-19 patients. Paquinimod, a specific inhibitor of S100A8/A9, could rescue the pneumonia with substantial reduction of viral loads in SARS-CoV-2-infected mice. Remarkably, Paquinimod treatment resulted in almost 100% survival in a lethal model of mouse coronavirus infection using the mouse hepatitis virus (MHV). A group of neutrophils that contributes to the uncontrolled pathological damage and onset of COVID-19 was dramatically induced by coronavirus infection. Paquinimod treatment could reduce these neutrophils and regain anti-viral responses, unveiling key roles of S100A8/A9 and aberrant neutrophils in the pathogenesis of COVID-19, highlighting new opportunities for therapeutic intervention. [Display omitted] •S100A8 is dramatically upregulated in SARS-CoV-2-infected animal models and patients•A group of aberrant immature neutrophils is induced during SARS-CoV-2 infection•Immune disorder is mediated by the S100A8/A9-TLR4 pathway•S100A8/A9 inhibitor, Paquinimod, could prevent COVID-19-associated immune disorder Guo et al. demonstrate that over-activation of S100A8/A9-TLR4 signaling results in immune imbalance and expansion of aberrant immature neutrophils during SARS-CoV-2 infection. Relevant therapeutic targets were validated in animal infection models.
Author You, Fuping
Guo, Qirui
Gao, Ran
Wang, Nan
Yang, Xiuhong
Kuang, Ming
Guo, Xuefei
Chen, Jingxuan
Xia, Huawei
Zhang, Zeming
Zhu, Hua
Qin, Chuan
Wang, Xiangxi
Luo, Yujie
Chen, Luoying
Wei, Xuemei
Zhao, Yingchi
Li, Junhong
Liu, Jiangning
Cao, Lili
Bao, Linlin
Deng, Wei
Wang, Xiao
Author_xml – sequence: 1
  givenname: Qirui
  surname: Guo
  fullname: Guo, Qirui
  organization: Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China
– sequence: 2
  givenname: Yingchi
  surname: Zhao
  fullname: Zhao, Yingchi
  organization: Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China
– sequence: 3
  givenname: Junhong
  surname: Li
  fullname: Li, Junhong
  organization: University of Chinese Academy of Sciences, CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
– sequence: 4
  givenname: Jiangning
  surname: Liu
  fullname: Liu, Jiangning
  organization: Key Laboratory of Human Disease Comparative Medicine, Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China
– sequence: 5
  givenname: Xiuhong
  surname: Yang
  fullname: Yang, Xiuhong
  organization: Key Laboratory of Human Disease Comparative Medicine, Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China
– sequence: 6
  givenname: Xuefei
  surname: Guo
  fullname: Guo, Xuefei
  organization: Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China
– sequence: 7
  givenname: Ming
  surname: Kuang
  fullname: Kuang, Ming
  organization: Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China
– sequence: 8
  givenname: Huawei
  surname: Xia
  fullname: Xia, Huawei
  organization: Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China
– sequence: 9
  givenname: Zeming
  surname: Zhang
  fullname: Zhang, Zeming
  organization: Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China
– sequence: 10
  givenname: Lili
  surname: Cao
  fullname: Cao, Lili
  organization: Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China
– sequence: 11
  givenname: Yujie
  surname: Luo
  fullname: Luo, Yujie
  organization: Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China
– sequence: 12
  givenname: Linlin
  surname: Bao
  fullname: Bao, Linlin
  organization: Key Laboratory of Human Disease Comparative Medicine, Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China
– sequence: 13
  givenname: Xiao
  surname: Wang
  fullname: Wang, Xiao
  organization: Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China
– sequence: 14
  givenname: Xuemei
  surname: Wei
  fullname: Wei, Xuemei
  organization: Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China
– sequence: 15
  givenname: Wei
  surname: Deng
  fullname: Deng, Wei
  organization: Key Laboratory of Human Disease Comparative Medicine, Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China
– sequence: 16
  givenname: Nan
  surname: Wang
  fullname: Wang, Nan
  organization: University of Chinese Academy of Sciences, CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
– sequence: 17
  givenname: Luoying
  surname: Chen
  fullname: Chen, Luoying
  organization: Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China
– sequence: 18
  givenname: Jingxuan
  surname: Chen
  fullname: Chen, Jingxuan
  organization: Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China
– sequence: 19
  givenname: Hua
  surname: Zhu
  fullname: Zhu, Hua
  organization: Key Laboratory of Human Disease Comparative Medicine, Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China
– sequence: 20
  givenname: Ran
  surname: Gao
  fullname: Gao, Ran
  organization: Key Laboratory of Human Disease Comparative Medicine, Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China
– sequence: 21
  givenname: Chuan
  surname: Qin
  fullname: Qin, Chuan
  email: qinchuan@pumc.edu.cn
  organization: Key Laboratory of Human Disease Comparative Medicine, Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China
– sequence: 22
  givenname: Xiangxi
  surname: Wang
  fullname: Wang, Xiangxi
  email: xiangxi@ibp.ac.cn
  organization: University of Chinese Academy of Sciences, CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
– sequence: 23
  givenname: Fuping
  surname: You
  fullname: You, Fuping
  email: fupingyou@hsc.pku.edu.cn
  organization: Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33388094$$D View this record in MEDLINE/PubMed
BookMark eNp9UctqGzEUFSWlebQ_0EWZZTfj6DEPCUrBuG1iCGSRtFuh0VxlZGYkV9IY8veV4yQkXWQlcXUeV-ecoiPnHSD0meAFwaQ53yz04KcFxTQP6CKP3qETIlhVNrgRRw93UjJC-TE6jXGDcV3jlnxAx4wxzrGoTtBm7fpZJ-td4U2hRhUm64obgvGSny9FMUFvVYJYqAzaqWdgByEolwoHcwp-O9gxFpmYBii2Kg3-DhxEG_fY1fWf9Y-SiI_ovVFjhE-P5xn6_evn7eqyvLq-WK-WV6WuK5FK1uT_YMVBMQwGQy0opQ3nYBQVfQ1GMK46SoEKxZuOGFH1gkBldCs0dIadoe8H3e3c5fU1uBTUKLfBTircS6-sfP3i7CDv_E62bUNbgrPA10eB4P_OEJOcbNQwjsqBn6OkVVtjzqtaZOiXl17PJk8BZwA_AHTwMQYwUtv0EGO2tqMkWO67lBu571Luu5SEyjzKVPof9Un9TdK3AwlywjsLQUZtwelcYwCdZO_tW_R_Uw-4kQ
CitedBy_id crossref_primary_10_1002_cac2_12388
crossref_primary_10_1016_j_jtha_2023_01_018
crossref_primary_10_1038_s41467_023_38842_6
crossref_primary_10_1186_s10020_024_00898_5
crossref_primary_10_3389_fimmu_2022_970287
crossref_primary_10_1007_s00011_024_01985_3
crossref_primary_10_3389_fimmu_2024_1294020
crossref_primary_10_3389_fmicb_2022_854172
crossref_primary_10_1002_jmv_70311
crossref_primary_10_3390_immuno2030033
crossref_primary_10_1093_bib_bbae482
crossref_primary_10_3389_fimmu_2023_1259879
crossref_primary_10_12677_jcpm_2024_34248
crossref_primary_10_3390_ijms23094894
crossref_primary_10_1002_mco2_90
crossref_primary_10_1038_s41467_024_55272_0
crossref_primary_10_3390_diagnostics12061324
crossref_primary_10_1016_j_xcrm_2022_100522
crossref_primary_10_1016_j_jprot_2024_105356
crossref_primary_10_1007_s00011_024_01937_x
crossref_primary_10_1007_s40495_023_00328_w
crossref_primary_10_1038_s42003_022_03035_2
crossref_primary_10_1126_sciimmunol_adg0033
crossref_primary_10_1016_j_intimp_2024_111788
crossref_primary_10_4110_in_2022_22_e22
crossref_primary_10_1002_btm2_70016
crossref_primary_10_1021_acs_jproteome_2c00219
crossref_primary_10_3389_fmed_2022_970423
crossref_primary_10_1016_j_biopha_2021_112346
crossref_primary_10_1016_j_isci_2022_105748
crossref_primary_10_1038_s42003_024_07025_4
crossref_primary_10_1016_j_ejim_2023_11_001
crossref_primary_10_1172_jci_insight_186133
crossref_primary_10_1007_s00011_023_01757_5
crossref_primary_10_1016_j_jinf_2021_11_017
crossref_primary_10_1007_s12011_021_02869_x
crossref_primary_10_1016_j_cyto_2024_156688
crossref_primary_10_1093_procel_pwac027
crossref_primary_10_1371_journal_ppat_1009850
crossref_primary_10_1038_s41467_022_32320_1
crossref_primary_10_2174_1389201023666220404183859
crossref_primary_10_3389_fimmu_2021_701273
crossref_primary_10_1053_j_gastro_2024_03_038
crossref_primary_10_1002_ijc_35128
crossref_primary_10_1126_sciimmunol_abm5505
crossref_primary_10_1016_j_jep_2023_117231
crossref_primary_10_3390_v16010027
crossref_primary_10_1080_1040841X_2024_2384885
crossref_primary_10_1002_jmv_28122
crossref_primary_10_1016_j_cytogfr_2021_10_004
crossref_primary_10_1111_bph_16013
crossref_primary_10_3390_v13122383
crossref_primary_10_3390_ijms24097717
crossref_primary_10_52794_hujpharm_1140957
crossref_primary_10_3390_cells11152274
crossref_primary_10_1167_iovs_66_1_35
crossref_primary_10_1016_j_jcyt_2021_12_003
crossref_primary_10_1161_CIRCULATIONAHA_123_064734
crossref_primary_10_3389_fimmu_2023_1254310
crossref_primary_10_1089_aid_2021_0193
crossref_primary_10_1002_prca_202200070
crossref_primary_10_1016_j_apmt_2024_102110
crossref_primary_10_1186_s40779_023_00462_y
crossref_primary_10_1038_s41577_023_00834_4
crossref_primary_10_3389_fimmu_2024_1302163
crossref_primary_10_3390_ijms222413480
crossref_primary_10_1016_j_jid_2023_05_028
crossref_primary_10_1007_s00423_022_02495_8
crossref_primary_10_1182_blood_2021014966
crossref_primary_10_1093_nsr_nwab143
crossref_primary_10_1021_acsinfecdis_3c00249
crossref_primary_10_1128_jvi_00967_22
crossref_primary_10_1038_s44161_022_00108_7
crossref_primary_10_18632_aging_204842
crossref_primary_10_1021_acsami_1c02755
crossref_primary_10_1016_j_smim_2021_101524
crossref_primary_10_4049_jimmunol_2300640
crossref_primary_10_1038_s41592_022_01709_7
crossref_primary_10_1093_jleuko_qiad099
crossref_primary_10_3389_fonc_2024_1344669
crossref_primary_10_3390_biomedicines10020382
crossref_primary_10_1016_j_intimp_2024_112963
crossref_primary_10_3389_fmolb_2022_952626
crossref_primary_10_1016_j_intimp_2023_109716
crossref_primary_10_1158_2326_6066_CIR_21_0675
crossref_primary_10_1016_j_biopha_2023_115674
crossref_primary_10_1073_pnas_2120680119
crossref_primary_10_1049_syb2_12080
crossref_primary_10_1111_cts_13400
crossref_primary_10_1016_j_bbcan_2023_188891
crossref_primary_10_1126_sciadv_adl5762
crossref_primary_10_1111_imr_13114
crossref_primary_10_3390_ijms24032112
crossref_primary_10_1080_1040841X_2024_2340643
crossref_primary_10_1155_2021_5488591
crossref_primary_10_1167_iovs_65_13_29
crossref_primary_10_1186_s12931_025_03181_1
crossref_primary_10_1111_imm_13850
crossref_primary_10_1016_j_intimp_2022_109277
crossref_primary_10_1371_journal_ppat_1011902
crossref_primary_10_3389_fimmu_2022_996637
crossref_primary_10_1016_j_bcp_2021_114847
crossref_primary_10_1016_j_redox_2025_103532
crossref_primary_10_1021_acs_jproteome_1c00506
crossref_primary_10_1128_mBio_02749_21
crossref_primary_10_1038_s41467_024_52818_0
crossref_primary_10_1016_j_cytogfr_2024_10_001
crossref_primary_10_1161_CIRCRESAHA_121_319142
crossref_primary_10_2147_JIR_S460413
crossref_primary_10_1016_j_cellsig_2024_111199
crossref_primary_10_3389_fimmu_2023_1024041
crossref_primary_10_1182_bloodadvances_2022008834
crossref_primary_10_3389_fimmu_2021_738073
crossref_primary_10_2147_JMDH_S495121
crossref_primary_10_1016_j_tim_2024_07_001
crossref_primary_10_3389_fimmu_2024_1479502
crossref_primary_10_1002_JLB_1MR1221_345R
crossref_primary_10_1016_j_freeradbiomed_2021_06_018
crossref_primary_10_3389_fcvm_2024_1394137
crossref_primary_10_3390_cells11121979
crossref_primary_10_1038_s41598_022_09343_1
crossref_primary_10_1186_s12943_021_01363_1
crossref_primary_10_3389_fphys_2021_752287
crossref_primary_10_1186_s12935_023_03136_w
crossref_primary_10_1016_j_apsb_2023_07_027
crossref_primary_10_1186_s40560_024_00740_4
crossref_primary_10_1016_j_molimm_2024_12_004
crossref_primary_10_1096_fj_202101013
crossref_primary_10_1038_s41392_021_00764_4
crossref_primary_10_1111_imr_13175
crossref_primary_10_1002_eji_202048984
crossref_primary_10_1002_fft2_477
crossref_primary_10_3389_fimmu_2021_697405
crossref_primary_10_1016_j_ebiom_2022_104077
crossref_primary_10_1016_j_phrs_2023_107029
crossref_primary_10_1038_s41598_022_05597_x
crossref_primary_10_1126_sciimmunol_abk1741
crossref_primary_10_1038_s41388_025_03276_5
crossref_primary_10_1007_s13258_022_01285_2
crossref_primary_10_1038_s41401_023_01188_2
crossref_primary_10_1097_SLA_0000000000006050
crossref_primary_10_1002_advs_202411823
crossref_primary_10_3389_fphar_2023_1187741
crossref_primary_10_1038_s41467_024_54689_x
crossref_primary_10_1038_s41590_021_00901_9
crossref_primary_10_1126_sciadv_abi6802
crossref_primary_10_1016_j_jid_2022_05_1085
crossref_primary_10_3389_fmicb_2023_1146694
crossref_primary_10_3389_fimmu_2021_680134
crossref_primary_10_1016_j_cej_2025_159903
crossref_primary_10_1186_s12951_021_00926_0
crossref_primary_10_1016_j_antiviral_2022_105345
crossref_primary_10_1126_scitranslmed_adh1315
crossref_primary_10_1111_cpr_13591
crossref_primary_10_3389_fimmu_2022_842535
Cites_doi 10.1016/j.mam.2014.05.001
10.1038/nm1638
10.1038/s41423-020-0402-2
10.1056/NEJMoa2001017
10.1093/cid/ciaa410
10.1038/nri2873
10.1136/annrheumdis-2014-206517
10.1126/science.abc6027
10.1038/s41423-020-0401-3
10.3390/ijms17050678
10.1016/j.cmet.2013.04.001
10.1038/s41418-020-00633-7
10.1007/s12250-014-3530-y
10.1007/s10495-015-1200-7
10.3389/fimmu.2020.00827
10.1371/journal.ppat.1000849
10.1093/nar/gkz114
10.1073/pnas.122244799
10.1016/j.immuni.2016.12.012
10.1038/s41467-019-09801-x
10.1016/j.cell.2020.04.026
10.1177/0363546517741127
10.1128/mBio.00638-15
10.1128/JVI.01130-10
10.1038/s41591-020-0901-9
10.1038/s41586-020-2008-3
10.1038/s41392-020-0148-4
10.1017/ice.2020.156
10.1038/nature01320
10.1111/imr.12577
10.1016/j.cell.2006.02.015
10.1016/j.coi.2005.06.002
10.1093/bioinformatics/bts515
10.4049/jimmunol.1402301
10.1371/journal.pone.0235458
10.1002/art.39938
10.1172/JCI62423
10.1016/j.heliyon.2020.e05116
10.1038/ni.2921
10.1001/jamainternmed.2020.0994
10.1007/s11882-018-0817-3
10.1038/s41590-020-0736-z
10.1189/jlb.0306164
10.1016/S0140-6736(20)30183-5
10.1016/j.meegid.2020.104587
10.1177/1535370216681551
10.3389/fimmu.2017.01493
10.1371/journal.pbio.1000097
10.1161/CIRCHEARTFAILURE.117.004125
10.1038/nm1124
10.1038/s41586-020-2312-y
10.1016/j.micinf.2012.10.008
10.1016/j.cell.2020.08.002
10.1172/JCI124804
10.1016/j.chom.2016.01.007
10.1016/j.cccn.2004.02.023
10.1038/s41591-020-0944-y
10.1016/j.cell.2020.08.001
10.1189/jlb.1012534
10.3389/fimmu.2018.01298
10.1038/ni.2756
10.1126/sciimmunol.abd7114
ContentType Journal Article
Copyright 2020 The Authors
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
2020 The Authors 2020
Copyright_xml – notice: 2020 The Authors
– notice: Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
– notice: 2020 The Authors 2020
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.chom.2020.12.016
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1934-6069
EndPage 235.e4
ExternalDocumentID PMC7762710
33388094
10_1016_j_chom_2020_12_016
S193131282030679X
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
0R~
1~5
29B
2WC
4.4
457
4G.
5GY
62-
6I.
6J9
7-5
AACTN
AAEDW
AAFTH
AAIAV
AAKRW
AALRI
AAUCE
AAVLU
AAXUO
ABJNI
ABMAC
ABMWF
ABVKL
ACGFO
ACGFS
ADBBV
ADEZE
ADJPV
AEFWE
AENEX
AEXQZ
AFTJW
AGKMS
AITUG
ALKID
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AZFZN
BAWUL
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FCP
FDB
FEDTE
HVGLF
IHE
IXB
JIG
K97
M41
O-L
O9-
OK1
P2P
RCE
ROL
RPZ
SES
SSZ
TR2
UNMZH
WQ6
ZA5
53G
AAEDT
AAIKJ
AAMRU
AAYWO
AAYXX
ABDGV
ACVFH
ADCNI
ADVLN
AEUPX
AFPUW
AGCQF
AGHFR
AIGII
AKAPO
AKBMS
AKRWK
AKYEP
APXCP
CITATION
HZ~
OZT
RIG
ZBA
CGR
CUY
CVF
ECM
EIF
NPM
7X8
EFKBS
5PM
ID FETCH-LOGICAL-c549t-360200a8ea30ef0e59222688efa29d5ef938ab22e29a86b1f94d91e4fc79cebf3
IEDL.DBID IXB
ISSN 1931-3128
1934-6069
IngestDate Thu Aug 21 18:13:56 EDT 2025
Mon Jul 21 10:33:16 EDT 2025
Thu Apr 03 07:06:36 EDT 2025
Tue Jul 01 02:44:22 EDT 2025
Thu Apr 24 23:11:08 EDT 2025
Fri Feb 23 02:48:36 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords aberrant neutrophils
Paquinimod
S100A8/A9
SARS-CoV-2
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c549t-360200a8ea30ef0e59222688efa29d5ef938ab22e29a86b1f94d91e4fc79cebf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work
Lead contact
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S193131282030679X
PMID 33388094
PQID 2475088459
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7762710
proquest_miscellaneous_2475088459
pubmed_primary_33388094
crossref_citationtrail_10_1016_j_chom_2020_12_016
crossref_primary_10_1016_j_chom_2020_12_016
elsevier_sciencedirect_doi_10_1016_j_chom_2020_12_016
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-02-10
PublicationDateYYYYMMDD 2021-02-10
PublicationDate_xml – month: 02
  year: 2021
  text: 2021-02-10
  day: 10
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cell host & microbe
PublicationTitleAlternate Cell Host Microbe
PublicationYear 2021
Publisher Elsevier Inc
The Authors. Published by Elsevier Inc
Publisher_xml – name: Elsevier Inc
– name: The Authors. Published by Elsevier Inc
References Bhattacharya, Sharma, Mallick, Sharma, Lee, Chakraborty (bib4) 2020; 85
Hanifehnezhad, Kehribar, Öztop, Sheraz, Kasırga, Ergünay, Önder, Yılmaz, Engin, Oğuzoğlu (bib21) 2020; 6
Vogl, Tenbrock, Ludwig, Leukert, Ehrhardt, van Zoelen, Nacken, Foell, van der Poll, Sorg, Roth (bib47) 2007; 13
Wang, Song, Wang, Jing, Wang, Ma (bib49) 2018; 9
Feng, Meyer, Wang, Liu, Shirley Liu, Zhang (bib16) 2012; 28
Zornetzer, Frieman, Rosenzweig, Korth, Page, Baric, Katze (bib63) 2010; 84
Huang, Wang, Li, Ren, Zhao, Hu, Zhang, Fan, Xu, Gu (bib22) 2020; 395
Li, Wang, Jou, Huang, Hsiao, Wan, Lin, Kung, Lin (bib27) 2016; 17
Zhang, Zhou, Qiu, Song, Feng, Feng, Song, Jia, Wang (bib58) 2020; 15
Narumi, Miyakawa, Ueda, Hashimoto, Yamamoto, Yoshida, Aoki (bib34) 2015; 194
Liao, Smyth, Shi (bib28) 2019; 47
Müller, Vogl, Pappritz, Miteva, Savvatis, Rohde, Most, Lassner, Pieske, Kühl (bib32) 2017; 10
Chu, Chan, Wang, Yuen, Chai, Hou, Shuai, Yang, Hu, Huang (bib13) 2020; 71
You, Wang, Yang, Yang, Zhao, Qian, Walker, Sutton, Montgomery, Lin (bib57) 2013; 14
Diao, Wang, Tan, Chen, Liu, Ning, Chen, Li, Liu, Wang (bib15) 2020; 11
Kang, Chen, Zhang, Hou, Wu, Cao, Huang, Yu, Fan, Yan (bib23) 2014; 40
Giri, Pabelick, Mukherjee, Prakash (bib19) 2016; 21
Totura, Whitmore, Agnihothram, Schäfer, Katze, Heise, Baric (bib46) 2015; 6
Bianchi (bib5) 2007; 81
Wilk, Rustagi, Zhao, Roque, Martínez-Colón, McKechnie, Ivison, Ranganath, Vergara, Hollis (bib50) 2020; 26
Cher, Akbar, Kitson, Crowe, Garcia-Melchor, Hannah, McLean, Fazzi, Kerr, Murrell, Millar (bib12) 2018; 46
Frieman, Chen, Morrison, Whitmore, Funkhouser, Ward, Lamirande, Roberts, Heise, Subbarao, Baric (bib18) 2010; 6
Yadav, Chi, Zhao, Tourdot, Yalavarthi, Jacobs, Banka, Liao, Koonse, Anyanwu (bib54) 2019; 129
Wang, Liao, Ochani, Justiniani, Lin, Yang, Al-Abed, Wang, Metz, Miller (bib48) 2004; 10
Zhu, Zhang, Wang, Li, Yang, Song, Zhao, Huang, Shi, Lu (bib62) 2020; 382
Akira, Uematsu, Takeuchi (bib1) 2006; 124
Tan, Wang, Zhang, Ding, Huang, Tang, Wang, Miao (bib45) 2020; 5
Chakraborty, Zenker, Rossaint, Hölscher, Pohlen, Zarbock, Roth, Vogl (bib8) 2017; 8
Kuri-Cervantes, Pampena, Meng, Rosenfeld, Ittner, Weisman, Agyekum, Mathew, Baxter, Vella (bib24) 2020; 5
Nathan (bib35) 2002; 420
Li, Chen, Cao, Zhu, Zheng, Zhou (bib26) 2013; 15
Nagareddy, Murphy, Stirzaker, Hu, Yu, Miller, Ramkhelawon, Distel, Westerterp, Huang (bib33) 2013; 17
Zheng, Gao, Wang, Song, Liu, Sun, Xu, Tian (bib60) 2020; 17
Hadjadj, Yatim, Barnabei, Corneau, Boussier, Smith, Péré, Charbit, Bondet, Chenevier-Gobeaux (bib20) 2020; 369
Björk, Björk, Vogl, Stenström, Liberg, Olsson, Roth, Ivars, Leanderson (bib6) 2009; 7
Blanco-Melo, Nilsson-Payant, Liu, Uhl, Hoagland, Møller, Jordan, Oishi, Panis, Sachs (bib7) 2020; 181
Li, Karlin, Loike, Silverstein (bib25) 2002; 99
Chen, Nuñez (bib11) 2010; 10
Matsuyama, Kubli, Yoshinaga, Pfeffer, Mak (bib30) 2020; 27
Patel (bib40) 2018; 18
Xie, Shi, Wu, Zhang, Kambara, Su, Yu, Park, Guo, Ren (bib53) 2020; 21
Yang, Han, Oppenheim (bib56) 2017; 280
Wu, Zhao, Yu, Chen, Wang, Song, Hu, Tao, Tian, Pei (bib52) 2020; 579
Zheng, Zhang, Yang, Zhang, Wang, Yang, Dong, Zheng (bib59) 2020; 17
Ometto, Friso, Astorri, Botsios, Raffeiner, Punzi, Doria (bib38) 2017; 242
Schelbergen, Geven, van den Bosch, Eriksson, Leanderson, Vogl, Roth, van de Loo, Koenders, van der Kraan (bib41) 2015; 74
Shi, Zuo, Yalavarthi, Gockman, Zuo, Madison, Blair, Woodward, Lezak, Lugogo (bib43) 2020
Bao, Deng, Huang, Gao, Liu, Ren, Wei, Yu, Xu, Qi (bib3) 2020; 583
Meng, Yalavarthi, Kanthi, Mazza, Elfline, Luke, Pinsky, Henke, Knight (bib31) 2017; 69
Liao, Liu, Yuan, Wen, Xu, Zhao, Cheng, Li, Wang, Wang (bib29) 2020; 26
Nauseef, Borregaard (bib36) 2014; 15
Yang, Du, Chen, Zhao, Yang, Su, Cheng, Tang (bib55) 2014; 29
Deng, Sarris, Bennin, Green, Herbomel, Huttenlocher (bib14) 2013; 93
Oppenheim, Yang (bib39) 2005; 17
Schulte-Schrepping, Reusch, Paclik, Baßler, Schlickeiser, Zhang, Krämer, Krammer, Brumhard, Bonaguro (bib42) 2020; 182
Zhou, Liu, Chen, Xiao, Huang, Fan (bib61) 2020; 41
Nicolás-Ávila, Adrover, Hidalgo (bib37) 2017; 46
Channappanavar, Fehr, Vijay, Mack, Zhao, Meyerholz, Perlman (bib10) 2016; 19
Foell, Frosch, Sorg, Roth (bib17) 2004; 344
Zuo, Yalavarthi, Shi, Gockman, Zuo, Madison, Blair, Weber, Barnes, Egeblad (bib64) 2020; 5
Chan, Roth, Oppenheim, Tracey, Vogl, Feldmann, Horwood, Nanchahal (bib9) 2012; 122
Ali, Gandhi, Meng, Yalavarthi, Vreede, Estes, Palmer, Bockenstedt, Pinsky, Greve (bib2) 2019; 10
Silvin, Chapuis, Dunsmore, Goubet, Dubuisson, Derosa, Almire, Hénon, Kosmider, Droin (bib44) 2020; 182
Wu, Chen, Cai, Xia, Zhou, Xu, Huang, Zhang, Zhou, Du (bib51) 2020; 180
Xie (10.1016/j.chom.2020.12.016_bib53) 2020; 21
Bianchi (10.1016/j.chom.2020.12.016_bib5) 2007; 81
Giri (10.1016/j.chom.2020.12.016_bib19) 2016; 21
You (10.1016/j.chom.2020.12.016_bib57) 2013; 14
Vogl (10.1016/j.chom.2020.12.016_bib47) 2007; 13
Zuo (10.1016/j.chom.2020.12.016_bib64) 2020; 5
Feng (10.1016/j.chom.2020.12.016_bib16) 2012; 28
Foell (10.1016/j.chom.2020.12.016_bib17) 2004; 344
Kang (10.1016/j.chom.2020.12.016_bib23) 2014; 40
Kuri-Cervantes (10.1016/j.chom.2020.12.016_bib24) 2020; 5
Liao (10.1016/j.chom.2020.12.016_bib28) 2019; 47
Chen (10.1016/j.chom.2020.12.016_bib11) 2010; 10
Nauseef (10.1016/j.chom.2020.12.016_bib36) 2014; 15
Deng (10.1016/j.chom.2020.12.016_bib14) 2013; 93
Zhu (10.1016/j.chom.2020.12.016_bib62) 2020; 382
Liao (10.1016/j.chom.2020.12.016_bib29) 2020; 26
Chan (10.1016/j.chom.2020.12.016_bib9) 2012; 122
Meng (10.1016/j.chom.2020.12.016_bib31) 2017; 69
Li (10.1016/j.chom.2020.12.016_bib26) 2013; 15
Zheng (10.1016/j.chom.2020.12.016_bib59) 2020; 17
Schelbergen (10.1016/j.chom.2020.12.016_bib41) 2015; 74
Frieman (10.1016/j.chom.2020.12.016_bib18) 2010; 6
Wang (10.1016/j.chom.2020.12.016_bib48) 2004; 10
Bao (10.1016/j.chom.2020.12.016_bib3) 2020; 583
Zornetzer (10.1016/j.chom.2020.12.016_bib63) 2010; 84
Cher (10.1016/j.chom.2020.12.016_bib12) 2018; 46
Akira (10.1016/j.chom.2020.12.016_bib1) 2006; 124
Chu (10.1016/j.chom.2020.12.016_bib13) 2020; 71
Wang (10.1016/j.chom.2020.12.016_bib49) 2018; 9
Chakraborty (10.1016/j.chom.2020.12.016_bib8) 2017; 8
Hanifehnezhad (10.1016/j.chom.2020.12.016_bib21) 2020; 6
Zhang (10.1016/j.chom.2020.12.016_bib58) 2020; 15
Zhou (10.1016/j.chom.2020.12.016_bib61) 2020; 41
Yang (10.1016/j.chom.2020.12.016_bib55) 2014; 29
Ometto (10.1016/j.chom.2020.12.016_bib38) 2017; 242
Ali (10.1016/j.chom.2020.12.016_bib2) 2019; 10
Oppenheim (10.1016/j.chom.2020.12.016_bib39) 2005; 17
Matsuyama (10.1016/j.chom.2020.12.016_bib30) 2020; 27
Wu (10.1016/j.chom.2020.12.016_bib52) 2020; 579
Diao (10.1016/j.chom.2020.12.016_bib15) 2020; 11
Müller (10.1016/j.chom.2020.12.016_bib32) 2017; 10
Wu (10.1016/j.chom.2020.12.016_bib51) 2020; 180
Bhattacharya (10.1016/j.chom.2020.12.016_bib4) 2020; 85
Totura (10.1016/j.chom.2020.12.016_bib46) 2015; 6
Tan (10.1016/j.chom.2020.12.016_bib45) 2020; 5
Schulte-Schrepping (10.1016/j.chom.2020.12.016_bib42) 2020; 182
Li (10.1016/j.chom.2020.12.016_bib27) 2016; 17
Wilk (10.1016/j.chom.2020.12.016_bib50) 2020; 26
Li (10.1016/j.chom.2020.12.016_bib25) 2002; 99
Nicolás-Ávila (10.1016/j.chom.2020.12.016_bib37) 2017; 46
Shi (10.1016/j.chom.2020.12.016_bib43) 2020
Björk (10.1016/j.chom.2020.12.016_bib6) 2009; 7
Channappanavar (10.1016/j.chom.2020.12.016_bib10) 2016; 19
Silvin (10.1016/j.chom.2020.12.016_bib44) 2020; 182
Nagareddy (10.1016/j.chom.2020.12.016_bib33) 2013; 17
Huang (10.1016/j.chom.2020.12.016_bib22) 2020; 395
Patel (10.1016/j.chom.2020.12.016_bib40) 2018; 18
Zheng (10.1016/j.chom.2020.12.016_bib60) 2020; 17
Blanco-Melo (10.1016/j.chom.2020.12.016_bib7) 2020; 181
Narumi (10.1016/j.chom.2020.12.016_bib34) 2015; 194
Yang (10.1016/j.chom.2020.12.016_bib56) 2017; 280
Yadav (10.1016/j.chom.2020.12.016_bib54) 2019; 129
Hadjadj (10.1016/j.chom.2020.12.016_bib20) 2020; 369
Nathan (10.1016/j.chom.2020.12.016_bib35) 2002; 420
References_xml – volume: 17
  start-page: 695
  year: 2013
  end-page: 708
  ident: bib33
  article-title: Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis
  publication-title: Cell Metab.
– volume: 47
  start-page: e47
  year: 2019
  ident: bib28
  article-title: The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads
  publication-title: Nucleic Acids Res.
– volume: 5
  start-page: 33
  year: 2020
  ident: bib45
  article-title: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
  publication-title: Signal Transduct. Target. Ther.
– volume: 40
  start-page: 1
  year: 2014
  end-page: 116
  ident: bib23
  article-title: HMGB1 in health and disease
  publication-title: Mol. Aspects Med.
– volume: 99
  start-page: 8289
  year: 2002
  end-page: 8294
  ident: bib25
  article-title: A critical concentration of neutrophils is required for effective bacterial killing in suspension
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 369
  start-page: 718
  year: 2020
  end-page: 724
  ident: bib20
  article-title: Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
  publication-title: Science
– volume: 17
  start-page: 541
  year: 2020
  end-page: 543
  ident: bib59
  article-title: Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
  publication-title: Cell. Mol. Immunol.
– volume: 5
  start-page: eabd7114
  year: 2020
  ident: bib24
  article-title: Comprehensive mapping of immune perturbations associated with severe COVID-19
  publication-title: Sci. Immunol.
– year: 2020
  ident: bib43
  article-title: Neutrophil calprotectin identifies severe pulmonary disease in COVID-19
  publication-title: J. Leukoc. Biol.
– volume: 10
  start-page: 1916
  year: 2019
  ident: bib2
  article-title: Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome
  publication-title: Nat. Commun.
– volume: 69
  start-page: 655
  year: 2017
  end-page: 667
  ident: bib31
  article-title: In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis
  publication-title: Arthritis Rheumatol.
– volume: 395
  start-page: 497
  year: 2020
  end-page: 506
  ident: bib22
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: Lancet
– volume: 85
  start-page: 104587
  year: 2020
  ident: bib4
  article-title: Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex
  publication-title: Infect. Genet. Evol.
– volume: 26
  start-page: 842
  year: 2020
  end-page: 844
  ident: bib29
  article-title: Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
  publication-title: Nat. Med.
– volume: 181
  start-page: 1036
  year: 2020
  end-page: 1045.e9
  ident: bib7
  article-title: Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
  publication-title: Cell
– volume: 27
  start-page: 3209
  year: 2020
  end-page: 3225
  ident: bib30
  article-title: An aberrant STAT pathway is central to COVID-19
  publication-title: Cell Death Differ.
– volume: 280
  start-page: 41
  year: 2017
  end-page: 56
  ident: bib56
  article-title: Alarmins and immunity
  publication-title: Immunol. Rev.
– volume: 182
  start-page: 1419
  year: 2020
  end-page: 1440.e23
  ident: bib42
  article-title: Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
  publication-title: Cell
– volume: 93
  start-page: 761
  year: 2013
  end-page: 769
  ident: bib14
  article-title: Localized bacterial infection induces systemic activation of neutrophils through Cxcr2 signaling in zebrafish
  publication-title: J. Leukoc. Biol.
– volume: 11
  start-page: 827
  year: 2020
  ident: bib15
  article-title: Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
  publication-title: Front. Immunol.
– volume: 583
  start-page: 830
  year: 2020
  end-page: 833
  ident: bib3
  article-title: The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
  publication-title: Nature
– volume: 242
  start-page: 859
  year: 2017
  end-page: 873
  ident: bib38
  article-title: Calprotectin in rheumatic diseases
  publication-title: Exp. Biol. Med. (Maywood)
– volume: 10
  start-page: e004125
  year: 2017
  ident: bib32
  article-title: Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis
  publication-title: Circ. Heart Fail.
– volume: 17
  start-page: 359
  year: 2005
  end-page: 365
  ident: bib39
  article-title: Alarmins: chemotactic activators of immune responses
  publication-title: Curr. Opin. Immunol.
– volume: 8
  start-page: 1493
  year: 2017
  ident: bib8
  article-title: Alarmin S100A8 Activates Alveolar Epithelial Cells in the Context of Acute Lung Injury in a TLR4-Dependent Manner
  publication-title: Front. Immunol.
– volume: 124
  start-page: 783
  year: 2006
  end-page: 801
  ident: bib1
  article-title: Pathogen recognition and innate immunity
  publication-title: Cell
– volume: 46
  start-page: 671
  year: 2018
  end-page: 678
  ident: bib12
  article-title: Alarmins in Frozen Shoulder: A Molecular Association Between Inflammation and Pain
  publication-title: Am. J. Sports Med.
– volume: 15
  start-page: 88
  year: 2013
  end-page: 95
  ident: bib26
  article-title: Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response
  publication-title: Microbes Infect.
– volume: 74
  start-page: 2254
  year: 2015
  end-page: 2258
  ident: bib41
  article-title: Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis
  publication-title: Ann. Rheum. Dis.
– volume: 17
  start-page: E678
  year: 2016
  ident: bib27
  article-title: SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6
  publication-title: Int. J. Mol. Sci.
– volume: 6
  start-page: e05116
  year: 2020
  ident: bib21
  article-title: Characterization of local SARS-CoV-2 isolates and pathogenicity in IFNAR
  publication-title: Heliyon
– volume: 10
  start-page: 826
  year: 2010
  end-page: 837
  ident: bib11
  article-title: Sterile inflammation: sensing and reacting to damage
  publication-title: Nat. Rev. Immunol.
– volume: 26
  start-page: 1070
  year: 2020
  end-page: 1076
  ident: bib50
  article-title: A single-cell atlas of the peripheral immune response in patients with severe COVID-19
  publication-title: Nat. Med.
– volume: 14
  start-page: 1237
  year: 2013
  end-page: 1246
  ident: bib57
  article-title: ELF4 is critical for induction of type I interferon and the host antiviral response
  publication-title: Nat. Immunol.
– volume: 382
  start-page: 727
  year: 2020
  end-page: 733
  ident: bib62
  article-title: A Novel Coronavirus from Patients with Pneumonia in China, 2019
  publication-title: N. Engl. J. Med.
– volume: 579
  start-page: 265
  year: 2020
  end-page: 269
  ident: bib52
  article-title: A new coronavirus associated with human respiratory disease in China
  publication-title: Nature
– volume: 29
  start-page: 393
  year: 2014
  end-page: 402
  ident: bib55
  article-title: Coronavirus MHV-A59 infects the lung and causes severe pneumonia in C57BL/6 mice
  publication-title: Virol. Sin.
– volume: 19
  start-page: 181
  year: 2016
  end-page: 193
  ident: bib10
  article-title: Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
  publication-title: Cell Host Microbe
– volume: 81
  start-page: 1
  year: 2007
  end-page: 5
  ident: bib5
  article-title: DAMPs, PAMPs and alarmins: all we need to know about danger
  publication-title: J. Leukoc. Biol.
– volume: 7
  start-page: e97
  year: 2009
  ident: bib6
  article-title: Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides
  publication-title: PLoS Biol.
– volume: 9
  start-page: 1298
  year: 2018
  ident: bib49
  article-title: S100A8/A9 in Inflammation
  publication-title: Front. Immunol.
– volume: 10
  start-page: 1216
  year: 2004
  end-page: 1221
  ident: bib48
  article-title: Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
  publication-title: Nat. Med.
– volume: 344
  start-page: 37
  year: 2004
  end-page: 51
  ident: bib17
  article-title: Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation
  publication-title: Clin. Chim. Acta
– volume: 129
  start-page: 2872
  year: 2019
  end-page: 2877
  ident: bib54
  article-title: Ectonucleotidase tri(di)phosphohydrolase-1 (ENTPD-1) disrupts inflammasome/interleukin 1β-driven venous thrombosis
  publication-title: J. Clin. Invest.
– volume: 71
  start-page: 1400
  year: 2020
  end-page: 1409
  ident: bib13
  article-title: Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19
  publication-title: Clin. Infect. Dis.
– volume: 6
  start-page: e00638-15
  year: 2015
  ident: bib46
  article-title: Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
  publication-title: MBio
– volume: 6
  start-page: e1000849
  year: 2010
  ident: bib18
  article-title: SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism
  publication-title: PLoS Pathog.
– volume: 17
  start-page: 533
  year: 2020
  end-page: 535
  ident: bib60
  article-title: Functional exhaustion of antiviral lymphocytes in COVID-19 patients
  publication-title: Cell. Mol. Immunol.
– volume: 194
  start-page: 5539
  year: 2015
  end-page: 5548
  ident: bib34
  article-title: Proinflammatory Proteins S100A8/S100A9 Activate NK Cells via Interaction with RAGE
  publication-title: J. Immunol.
– volume: 18
  start-page: 63
  year: 2018
  ident: bib40
  article-title: Danger-Associated Molecular Patterns (DAMPs): the Derivatives and Triggers of Inflammation
  publication-title: Curr. Allergy Asthma Rep.
– volume: 182
  start-page: 1401
  year: 2020
  end-page: 1418.e18
  ident: bib44
  article-title: Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
  publication-title: Cell
– volume: 15
  start-page: e0235458
  year: 2020
  ident: bib58
  article-title: Clinical characteristics of 82 cases of death from COVID-19
  publication-title: PLoS One
– volume: 15
  start-page: 602
  year: 2014
  end-page: 611
  ident: bib36
  article-title: Neutrophils at work
  publication-title: Nat. Immunol.
– volume: 21
  start-page: 1119
  year: 2020
  end-page: 1133
  ident: bib53
  article-title: Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection
  publication-title: Nat. Immunol.
– volume: 180
  start-page: 934
  year: 2020
  end-page: 943
  ident: bib51
  article-title: Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
  publication-title: JAMA Intern. Med.
– volume: 46
  start-page: 15
  year: 2017
  end-page: 28
  ident: bib37
  article-title: Neutrophils in Homeostasis, Immunity, and Cancer
  publication-title: Immunity
– volume: 21
  start-page: 329
  year: 2016
  end-page: 339
  ident: bib19
  article-title: Hepatoma derived growth factor (HDGF) dynamics in ovarian cancer cells
  publication-title: Apoptosis
– volume: 122
  start-page: 2711
  year: 2012
  end-page: 2719
  ident: bib9
  article-title: Alarmins: awaiting a clinical response
  publication-title: J. Clin. Invest.
– volume: 84
  start-page: 11297
  year: 2010
  end-page: 11309
  ident: bib63
  article-title: Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection
  publication-title: J. Virol.
– volume: 5
  start-page: 138999
  year: 2020
  ident: bib64
  article-title: Neutrophil extracellular traps in COVID-19
  publication-title: JCI Insight
– volume: 420
  start-page: 846
  year: 2002
  end-page: 852
  ident: bib35
  article-title: Points of control in inflammation
  publication-title: Nature
– volume: 13
  start-page: 1042
  year: 2007
  end-page: 1049
  ident: bib47
  article-title: Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock
  publication-title: Nat. Med.
– volume: 41
  start-page: 1124
  year: 2020
  end-page: 1125
  ident: bib61
  article-title: Bacterial and fungal infections in COVID-19 patients: A matter of concern
  publication-title: Infect. Control Hosp. Epidemiol.
– volume: 28
  start-page: 2782
  year: 2012
  end-page: 2788
  ident: bib16
  article-title: GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data
  publication-title: Bioinformatics
– volume: 5
  start-page: 138999
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib64
  article-title: Neutrophil extracellular traps in COVID-19
  publication-title: JCI Insight
– volume: 40
  start-page: 1
  year: 2014
  ident: 10.1016/j.chom.2020.12.016_bib23
  article-title: HMGB1 in health and disease
  publication-title: Mol. Aspects Med.
  doi: 10.1016/j.mam.2014.05.001
– volume: 13
  start-page: 1042
  year: 2007
  ident: 10.1016/j.chom.2020.12.016_bib47
  article-title: Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock
  publication-title: Nat. Med.
  doi: 10.1038/nm1638
– volume: 17
  start-page: 533
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib60
  article-title: Functional exhaustion of antiviral lymphocytes in COVID-19 patients
  publication-title: Cell. Mol. Immunol.
  doi: 10.1038/s41423-020-0402-2
– volume: 382
  start-page: 727
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib62
  article-title: A Novel Coronavirus from Patients with Pneumonia in China, 2019
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2001017
– volume: 71
  start-page: 1400
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib13
  article-title: Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciaa410
– volume: 10
  start-page: 826
  year: 2010
  ident: 10.1016/j.chom.2020.12.016_bib11
  article-title: Sterile inflammation: sensing and reacting to damage
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2873
– volume: 74
  start-page: 2254
  year: 2015
  ident: 10.1016/j.chom.2020.12.016_bib41
  article-title: Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/annrheumdis-2014-206517
– volume: 369
  start-page: 718
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib20
  article-title: Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
  publication-title: Science
  doi: 10.1126/science.abc6027
– volume: 17
  start-page: 541
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib59
  article-title: Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
  publication-title: Cell. Mol. Immunol.
  doi: 10.1038/s41423-020-0401-3
– volume: 17
  start-page: E678
  year: 2016
  ident: 10.1016/j.chom.2020.12.016_bib27
  article-title: SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms17050678
– volume: 17
  start-page: 695
  year: 2013
  ident: 10.1016/j.chom.2020.12.016_bib33
  article-title: Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2013.04.001
– volume: 27
  start-page: 3209
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib30
  article-title: An aberrant STAT pathway is central to COVID-19
  publication-title: Cell Death Differ.
  doi: 10.1038/s41418-020-00633-7
– volume: 29
  start-page: 393
  year: 2014
  ident: 10.1016/j.chom.2020.12.016_bib55
  article-title: Coronavirus MHV-A59 infects the lung and causes severe pneumonia in C57BL/6 mice
  publication-title: Virol. Sin.
  doi: 10.1007/s12250-014-3530-y
– volume: 21
  start-page: 329
  year: 2016
  ident: 10.1016/j.chom.2020.12.016_bib19
  article-title: Hepatoma derived growth factor (HDGF) dynamics in ovarian cancer cells
  publication-title: Apoptosis
  doi: 10.1007/s10495-015-1200-7
– volume: 11
  start-page: 827
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib15
  article-title: Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2020.00827
– volume: 6
  start-page: e1000849
  year: 2010
  ident: 10.1016/j.chom.2020.12.016_bib18
  article-title: SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1000849
– volume: 47
  start-page: e47
  year: 2019
  ident: 10.1016/j.chom.2020.12.016_bib28
  article-title: The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkz114
– volume: 99
  start-page: 8289
  year: 2002
  ident: 10.1016/j.chom.2020.12.016_bib25
  article-title: A critical concentration of neutrophils is required for effective bacterial killing in suspension
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.122244799
– volume: 46
  start-page: 15
  year: 2017
  ident: 10.1016/j.chom.2020.12.016_bib37
  article-title: Neutrophils in Homeostasis, Immunity, and Cancer
  publication-title: Immunity
  doi: 10.1016/j.immuni.2016.12.012
– volume: 10
  start-page: 1916
  year: 2019
  ident: 10.1016/j.chom.2020.12.016_bib2
  article-title: Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-09801-x
– year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib43
  article-title: Neutrophil calprotectin identifies severe pulmonary disease in COVID-19
  publication-title: J. Leukoc. Biol.
– volume: 181
  start-page: 1036
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib7
  article-title: Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
  publication-title: Cell
  doi: 10.1016/j.cell.2020.04.026
– volume: 46
  start-page: 671
  year: 2018
  ident: 10.1016/j.chom.2020.12.016_bib12
  article-title: Alarmins in Frozen Shoulder: A Molecular Association Between Inflammation and Pain
  publication-title: Am. J. Sports Med.
  doi: 10.1177/0363546517741127
– volume: 6
  start-page: e00638-15
  year: 2015
  ident: 10.1016/j.chom.2020.12.016_bib46
  article-title: Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
  publication-title: MBio
  doi: 10.1128/mBio.00638-15
– volume: 84
  start-page: 11297
  year: 2010
  ident: 10.1016/j.chom.2020.12.016_bib63
  article-title: Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection
  publication-title: J. Virol.
  doi: 10.1128/JVI.01130-10
– volume: 26
  start-page: 842
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib29
  article-title: Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-0901-9
– volume: 579
  start-page: 265
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib52
  article-title: A new coronavirus associated with human respiratory disease in China
  publication-title: Nature
  doi: 10.1038/s41586-020-2008-3
– volume: 5
  start-page: 33
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib45
  article-title: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
  publication-title: Signal Transduct. Target. Ther.
  doi: 10.1038/s41392-020-0148-4
– volume: 41
  start-page: 1124
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib61
  article-title: Bacterial and fungal infections in COVID-19 patients: A matter of concern
  publication-title: Infect. Control Hosp. Epidemiol.
  doi: 10.1017/ice.2020.156
– volume: 420
  start-page: 846
  year: 2002
  ident: 10.1016/j.chom.2020.12.016_bib35
  article-title: Points of control in inflammation
  publication-title: Nature
  doi: 10.1038/nature01320
– volume: 280
  start-page: 41
  year: 2017
  ident: 10.1016/j.chom.2020.12.016_bib56
  article-title: Alarmins and immunity
  publication-title: Immunol. Rev.
  doi: 10.1111/imr.12577
– volume: 124
  start-page: 783
  year: 2006
  ident: 10.1016/j.chom.2020.12.016_bib1
  article-title: Pathogen recognition and innate immunity
  publication-title: Cell
  doi: 10.1016/j.cell.2006.02.015
– volume: 17
  start-page: 359
  year: 2005
  ident: 10.1016/j.chom.2020.12.016_bib39
  article-title: Alarmins: chemotactic activators of immune responses
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/j.coi.2005.06.002
– volume: 28
  start-page: 2782
  year: 2012
  ident: 10.1016/j.chom.2020.12.016_bib16
  article-title: GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bts515
– volume: 194
  start-page: 5539
  year: 2015
  ident: 10.1016/j.chom.2020.12.016_bib34
  article-title: Proinflammatory Proteins S100A8/S100A9 Activate NK Cells via Interaction with RAGE
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1402301
– volume: 15
  start-page: e0235458
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib58
  article-title: Clinical characteristics of 82 cases of death from COVID-19
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0235458
– volume: 69
  start-page: 655
  year: 2017
  ident: 10.1016/j.chom.2020.12.016_bib31
  article-title: In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis
  publication-title: Arthritis Rheumatol.
  doi: 10.1002/art.39938
– volume: 122
  start-page: 2711
  year: 2012
  ident: 10.1016/j.chom.2020.12.016_bib9
  article-title: Alarmins: awaiting a clinical response
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI62423
– volume: 6
  start-page: e05116
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib21
  article-title: Characterization of local SARS-CoV-2 isolates and pathogenicity in IFNAR-/- mice
  publication-title: Heliyon
  doi: 10.1016/j.heliyon.2020.e05116
– volume: 15
  start-page: 602
  year: 2014
  ident: 10.1016/j.chom.2020.12.016_bib36
  article-title: Neutrophils at work
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.2921
– volume: 180
  start-page: 934
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib51
  article-title: Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
  publication-title: JAMA Intern. Med.
  doi: 10.1001/jamainternmed.2020.0994
– volume: 18
  start-page: 63
  year: 2018
  ident: 10.1016/j.chom.2020.12.016_bib40
  article-title: Danger-Associated Molecular Patterns (DAMPs): the Derivatives and Triggers of Inflammation
  publication-title: Curr. Allergy Asthma Rep.
  doi: 10.1007/s11882-018-0817-3
– volume: 21
  start-page: 1119
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib53
  article-title: Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection
  publication-title: Nat. Immunol.
  doi: 10.1038/s41590-020-0736-z
– volume: 81
  start-page: 1
  year: 2007
  ident: 10.1016/j.chom.2020.12.016_bib5
  article-title: DAMPs, PAMPs and alarmins: all we need to know about danger
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.0306164
– volume: 395
  start-page: 497
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib22
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30183-5
– volume: 85
  start-page: 104587
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib4
  article-title: Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex
  publication-title: Infect. Genet. Evol.
  doi: 10.1016/j.meegid.2020.104587
– volume: 242
  start-page: 859
  year: 2017
  ident: 10.1016/j.chom.2020.12.016_bib38
  article-title: Calprotectin in rheumatic diseases
  publication-title: Exp. Biol. Med. (Maywood)
  doi: 10.1177/1535370216681551
– volume: 8
  start-page: 1493
  year: 2017
  ident: 10.1016/j.chom.2020.12.016_bib8
  article-title: Alarmin S100A8 Activates Alveolar Epithelial Cells in the Context of Acute Lung Injury in a TLR4-Dependent Manner
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2017.01493
– volume: 7
  start-page: e97
  year: 2009
  ident: 10.1016/j.chom.2020.12.016_bib6
  article-title: Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides
  publication-title: PLoS Biol.
  doi: 10.1371/journal.pbio.1000097
– volume: 10
  start-page: e004125
  year: 2017
  ident: 10.1016/j.chom.2020.12.016_bib32
  article-title: Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis
  publication-title: Circ. Heart Fail.
  doi: 10.1161/CIRCHEARTFAILURE.117.004125
– volume: 10
  start-page: 1216
  year: 2004
  ident: 10.1016/j.chom.2020.12.016_bib48
  article-title: Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
  publication-title: Nat. Med.
  doi: 10.1038/nm1124
– volume: 583
  start-page: 830
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib3
  article-title: The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
  publication-title: Nature
  doi: 10.1038/s41586-020-2312-y
– volume: 15
  start-page: 88
  year: 2013
  ident: 10.1016/j.chom.2020.12.016_bib26
  article-title: Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response
  publication-title: Microbes Infect.
  doi: 10.1016/j.micinf.2012.10.008
– volume: 182
  start-page: 1401
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib44
  article-title: Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
  publication-title: Cell
  doi: 10.1016/j.cell.2020.08.002
– volume: 129
  start-page: 2872
  year: 2019
  ident: 10.1016/j.chom.2020.12.016_bib54
  article-title: Ectonucleotidase tri(di)phosphohydrolase-1 (ENTPD-1) disrupts inflammasome/interleukin 1β-driven venous thrombosis
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI124804
– volume: 19
  start-page: 181
  year: 2016
  ident: 10.1016/j.chom.2020.12.016_bib10
  article-title: Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2016.01.007
– volume: 344
  start-page: 37
  year: 2004
  ident: 10.1016/j.chom.2020.12.016_bib17
  article-title: Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation
  publication-title: Clin. Chim. Acta
  doi: 10.1016/j.cccn.2004.02.023
– volume: 26
  start-page: 1070
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib50
  article-title: A single-cell atlas of the peripheral immune response in patients with severe COVID-19
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-0944-y
– volume: 182
  start-page: 1419
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib42
  article-title: Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
  publication-title: Cell
  doi: 10.1016/j.cell.2020.08.001
– volume: 93
  start-page: 761
  year: 2013
  ident: 10.1016/j.chom.2020.12.016_bib14
  article-title: Localized bacterial infection induces systemic activation of neutrophils through Cxcr2 signaling in zebrafish
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.1012534
– volume: 9
  start-page: 1298
  year: 2018
  ident: 10.1016/j.chom.2020.12.016_bib49
  article-title: S100A8/A9 in Inflammation
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2018.01298
– volume: 14
  start-page: 1237
  year: 2013
  ident: 10.1016/j.chom.2020.12.016_bib57
  article-title: ELF4 is critical for induction of type I interferon and the host antiviral response
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.2756
– volume: 5
  start-page: eabd7114
  year: 2020
  ident: 10.1016/j.chom.2020.12.016_bib24
  article-title: Comprehensive mapping of immune perturbations associated with severe COVID-19
  publication-title: Sci. Immunol.
  doi: 10.1126/sciimmunol.abd7114
SSID ssj0055071
Score 2.644562
Snippet The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses an unprecedented public health crisis. Evidence suggests that SARS-CoV-2...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 222
SubjectTerms aberrant neutrophils
Alarmins - pharmacology
Animals
Antiviral Agents - pharmacology
COVID-19 - metabolism
COVID-19 - virology
COVID-19 Drug Treatment
Disease Models, Animal
Female
Humans
Macaca mulatta
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Neutrophils - drug effects
Neutrophils - metabolism
Paquinimod
S100A8/A9
SARS-CoV-2
SARS-CoV-2 - drug effects
Transcriptome
Viral Load
Title Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19
URI https://dx.doi.org/10.1016/j.chom.2020.12.016
https://www.ncbi.nlm.nih.gov/pubmed/33388094
https://www.proquest.com/docview/2475088459
https://pubmed.ncbi.nlm.nih.gov/PMC7762710
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqSkhcEOW5QCsjcUPR-pGXj9ttqxYEHErR3izHmdBUbbLazR7675lxkhULqAeuyYzkeCYz39jzYOyDAJkWICBKtUsxQEnLyCQlROAd6k9SSCipGvnL1_T8Kv60SBZ7bD7WwlBa5WD7e5serPXwZDrs5nRZ19NLhB5So3lVAfaaBdphHeehiG9xPFpjatcl-5tlGRH1UDjT53jRPBKMEZUIR4I08_zfzulv8PlnDuVvTunsKXsyoEk-6xd8wPagecYe9fMl75-zGxrMEQoXeFtxh0HsXd3wSynELJ_ODA9lI4g1OVU39GezgbCAFbqwjjew6Vbt8rq-XXNkRKzIaYJx-5MMZL0m2vm3HxcnkTQv2NXZ6ff5eTQMV4g8hoRdpFP8bOFycFpAJSAxiBTSPIfKKVMmUBmdu0IpUMblaSErE5dGQlz5zHgoKv2S7TdtA68ZT1zlK698XnodI4OD0sXK-yxzIvfCTZgcd9X6ofM4DcC4tWOK2Y0lSViShJXK4qMJ-7jlWfZ9Nx6kTkZh2R3tsegYHuR7P0rW4m9FdyWugXaztirOCLrGiZmwV72kt-vQmjromHjCsh0d2BJQy-7dN019HVp3Z-h7ENO9-c_1vmWPFeXU0EAa8Y7td6sNHCIo6oojDAcuPh8F3f8FQE0M8w
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELZKEYJLxZuUl5G4oVVs79PHEKgSaMuhLcrN8nrH7VZlN0o2B_49M_uICKAeuHpnJK_HnvnGngdj7wXIJAcBQRLaBB2UpAh0XEAAzuL-iXMJBWUjn5wms4voyyJe7LHpkAtDYZW97u90equt-5Fxv5rjZVmOzxB6yBDVq2phr17cYXcRDaR0OueLj4M6pnpdsntalgGR95kzXZAXNSRBJ1GJ9k6Qmp7_2zr9jT7_DKL8zSodPWQHPZzkk27Gj9geVI_Zva7B5M8n7Jo6c7SZC7z23KIX-6Os-JkUYpKNJ5q3eSMINjmlN3SXsy1hDiu0YQ2vYNOs6uVVebPmyIhgkVML4_qSNGS5Jtrpt-_zT4HUT9nF0efz6SzouysEDn3CJggT_G1hM7ChAC8g1ggVkiwDb5UuYvA6zGyuFChtsySXXkeFlhB5l2oHuQ-fsf2qruAF47H1zjvlssKFETJYKGyknEtTKzIn7IjJYVWN60uPUweMGzPEmF0bkoQhSRipDA6N2Ictz7IrvHErdTwIy-xsH4OW4Va-d4NkDZ4reiyxFdSbtVFRStg1ivWIPe8kvZ1HGFIJHR2NWLqzB7YEVLN790tVXrW1u1M0PgjqDv9zvm_Z_dn5ybE5np9-fckeKAqwoe404hXbb1YbeI0IqcnftCfgF2-IDxo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Induction+of+alarmin+S100A8%2FA9+mediates+activation+of+aberrant+neutrophils+in+the+pathogenesis+of+COVID-19&rft.jtitle=Cell+host+%26+microbe&rft.au=Guo%2C+Qirui&rft.au=Zhao%2C+Yingchi&rft.au=Li%2C+Junhong&rft.au=Liu%2C+Jiangning&rft.date=2021-02-10&rft.eissn=1934-6069&rft.volume=29&rft.issue=2&rft.spage=222&rft_id=info:doi/10.1016%2Fj.chom.2020.12.016&rft_id=info%3Apmid%2F33388094&rft.externalDocID=33388094
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1931-3128&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1931-3128&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1931-3128&client=summon